Hit Enter to search or Esc to close
0
Epalrestat

Epalrestat

CAS NO.: 82159-09-9
MF: C15H13NO3S2
EINECS NO.: 675-018-0
API178
Quantity
Send Inquiry
add to cart

Product Name
Epalrestat
Appearance
Yellow to orange powder
Specification
 99%
Test Method
HPLC
Storage
Keep in a cool, dry, dark location in a tightly sealed container or cylinder.
Shelf Time
24 months

Epalrestat is used as aldose reductase inhibitor, can reversibly inhibit the glucose into sorbitol and the role of aldose reductase.

Obstacle for diabetic nerve endings caused by symptoms, vibration sense abnormalities, abnormal changes in heart rate improved.

Epalrestat is the second aldose reductase inhibitor to be introduced worldwide and the first to be launched in Japan.
The compound is indicated for the treatment of diabetic neuropathy.
It is also being investigated for diabetic retinopathy and nephropathy.